Apyx Medical (NASDAQ: APYX) director awarded 450,000 restricted stock units
Rhea-AI Filing Summary
Vizirgianakis Stavros G. reported acquisition or exercise transactions in this Form 4 filing.
Apyx Medical Corp director Stavros G. Vizirgianakis received a grant of 450,000 restricted stock units (RSUs). The award was granted at no cash cost per unit and is compensation rather than an open-market purchase.
According to the vesting schedule, 150,000 RSUs vest on June 11, 2026, 150,000 begin vesting on the first anniversary of that date and vest ratably over the following twelve months, and the remaining 150,000 follow the same ratable schedule starting on the second anniversary. After this grant, Vizirgianakis directly holds 2,196,191 shares or share-equivalents reported in this filing.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 450,000 shares
Net Buy
1 txn
Insider
Vizirgianakis Stavros G.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 450,000 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Units — 2,196,191 shares (Direct)
Footnotes (1)
- F1. The restricted stock units vest as follows: (i) 150,000 restricted stock units vest immediately on June 11, 2026 (the "Grant Date"); (ii) 150,000 restricted stock units will commence vesting on the first anniversary of the Grant Date and will vest ratably over the twelve (12) month period beginning on such date; and (iii) 150,000 restricted stock units will commence vesting on the second anniversary of the Grant Date and will vest ratably over the twelve (12) month period beginning on such date, in each case subject to the Reporting Person's continued service through each applicable vesting date and the terms and conditions of the applicable award agreement.
Key Figures
RSUs granted: 450,000 units
Immediate vesting tranche: 150,000 units
First anniversary vesting: 150,000 units
+3 more
6 metrics
RSUs granted
450,000 units
Restricted stock units awarded to director on June 11, 2026
Immediate vesting tranche
150,000 units
RSUs vesting on June 11, 2026
First anniversary vesting
150,000 units
RSUs vesting ratably over 12 months starting first anniversary of grant date
Second anniversary vesting
150,000 units
RSUs vesting ratably over 12 months starting second anniversary of grant date
Post-grant holdings
2,196,191 shares
Total direct holdings following reported transaction
Grant price
$0.00 per unit
Stated transaction price for RSU award
Key Terms
Restricted Stock Units, vest ratably, award agreement
3 terms
Restricted Stock Units financial
"The restricted stock units vest as follows: (i) 150,000 restricted stock units vest immediately..."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
vest ratably financial
"150,000 restricted stock units will commence vesting on the first anniversary ... and will vest ratably over the twelve (12) month period"
award agreement financial
"subject to the Reporting Person's continued service ... and the terms and conditions of the applicable award agreement"
An award agreement is a legal contract that spells out the terms of a pay or equity grant—such as stock options, restricted shares, or cash bonuses—given to an employee, director or consultant. It describes what is being granted, any conditions for keeping it (for example, earning it over time or meeting performance targets), and what happens if the person leaves or breaks rules. Investors care because these agreements affect company costs, potential share dilution and how executives are motivated and rewarded.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Apyx Medical (APYX) disclose for Stavros G. Vizirgianakis?
Apyx Medical disclosed that director Stavros G. Vizirgianakis received a grant of 450,000 restricted stock units. The RSUs were awarded as equity compensation, not through an open-market purchase, and were reported as a direct ownership acquisition.
How many Apyx Medical (APYX) RSUs were granted and at what price?
The director was granted 450,000 restricted stock units of Apyx Medical at a stated price of $0.00 per unit. This reflects a compensation award, meaning no cash was paid to acquire the units in this transaction.
What is the vesting schedule for the 450,000 Apyx Medical (APYX) RSUs?
The 450,000 RSUs vest in three tranches of 150,000 each. The first vests on June 11, 2026, the second vests ratably over twelve months starting one year later, and the third vests ratably over twelve months starting two years after the grant date.
What ongoing service conditions apply to the Apyx Medical (APYX) RSU award?
Each RSU tranche is subject to the director’s continued service through the applicable vesting dates. The award is also governed by the terms and conditions of the applicable award agreement, which can affect vesting and forfeiture outcomes.